Dr. King is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
21 Spurs Ln
Suite 100
San Antonio, TX 78240Phone+1 210-614-6070
Education & Training
- Texas Neuroscience InstituteFellowship, Neurotology, 1995 - 1996
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Otolaryngology - Head and Neck Surgery, 1990 - 1994
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineInternship, Otolaryngology - Head and Neck Surgery, 1989 - 1990
- Creighton University School of MedicineClass of 1989
Certifications & Licensure
- TX State Medical License 1990 - 2026
- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
- American Board of Otolaryngology - Head and Neck Surgery Neurotology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity Practice Solution EMR, GE Healthcare, 2014
- Super Doctor SuperDoctors.com
- Fellow (FACS) American College of Surgeons
- Join now to see all
Publications & Presentations
PubMed
- 25 citationsImproved Speech Intelligibility in Subjects With Stable Sensorineural Hearing Loss Following Intratympanic Dosing of FX-322 in a Phase 1b Study.Will Mclean, Ashley S. Hinton, Jenna T.J. Herby, Alec N. Salt, Jared J. Hartsock
Otology & Neurotology. 2021-02-22 - 11 citationsConsideration for routine outpatient pediatric cochlear implantation: A retrospective chart review of immediate post-operative complications.Sunthosh Sivam, Charles A. Syms, Susan M. King, Brian Perry
International Journal of Pediatric Otorhinolaryngology. 2017-03-01 - 7 citationsConsensus statement from the consensus conference on blood-borne human immunodeficiency virus and hepatitis: optimizing the donor-selection process.Susan M. King, James P. AuBuchon, N. Barrowman, G. Follea, M. Giroux
Vox Sanguinis. 2002-08-01
Press Mentions
- Frequency Therapeutics Announces Positive Phase 1/2 Data for Drug Candidate for Hearing RestorationApril 9th, 2019
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: